Clinical Trial Update: The Effect of Ketamine on Attentiveness [Phase 1]

View source ↗

Summary

Phase 1 trial update examining the effect of ketamine on attentiveness in individuals with schizophrenia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED